The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases

Arthritis Research and Therapy

Volumn 11, Issue 3, 2009, Pages

  Gabay, Cem ^a   McInnes, Iain B ^b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMG 714; ANTIBODY; ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ST2; INTERLEUKIN 1 RECEPTOR ST2 ANTIBODY; INTERLEUKIN 1 RECEPTOR T1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN 1F6; INTERLEUKIN 1F7; INTERLEUKIN 1F8; INTERLEUKIN 21; INTERLEUKIN 27; INTERLEUKIN 33; INTERLEUKIN 6; PLACEBO; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; AUTOIMMUNITY; BIOLOGICAL ACTIVITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG TARGETING; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; ISCHEMIA; JUVENILE RHEUMATOID ARTHRITIS; NONHUMAN; OSTEOARTHRITIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PSORIASIS; RECEPTOR BINDING; REPERFUSION INJURY; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; SPONDYLOARTHROPATHY; SYNOVITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; CYTOKINES; HUMANS; RHEUMATIC DISEASES; SIGNAL TRANSDUCTION;

EID: 66149186881     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2680     Document Type: Review

References (135)

1. Dunn E Sims JE Nicklin MJ O'Neill LA Annotating genes with potential roles in the immune system: Six new members of the IL-1 family Trends Immunol 2001, 22:533-536. 10.1016/S1471-4906(01)02034-8 11574261
2. Barksby HE Lea SR Preshaw PM Taylor JJ The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders Clin Exp Immunol 2007, 149:217-225. 1941943 17590166
3. Barton JL Herbst R Bosisio D Higgins L Nicklin MJ A tissue specific IL-1 receptor antagonist homolog from the IL-1 cluster lacks IL-1, IL-1ra, IL-18 and IL-18 antagonist activities Eur J Immunol 2000, 30:3299-3308. 10.1002/1521-4141(200011)30:11<3299::AID-IMMU3299>3.0.CO;2-S 11093146
4. Busfield SJ Comrack CA Yu G Chickering TW Smutko JS Zhou H Leiby KR Holmgren LM Gearing DP Pan Y Identification and gene organization of three novel members of the IL-1 family on human chromosome 2 Genomics 2000, 66:213-216. 10.1006/geno.2000.6184 10860666
5. Debets R Timans JC Homey B Zurawski S Sana TR Lo S Wagner J Edwards G Clifford T Menon S Bazan JF Kastelein RA Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2 J Immunol 2001 167 1440 1446 11466363
6. Kumar S McDonnell PC Lehr R Tierney L Tzimas MN Griswold DE Capper EA Tal-Singer R Wells GI Doyle ML Young PR Identification and initial characterization of four novel members of the interleukin-1 family J Biol Chem 2000, 275:10308-10314. 10.1074/jbc.275.14.10308 10744718
7. Mulero JJ Pace AM Nelken ST Loeb DB Correa TR Drmanac R Ford JE IL1HY1: a novel interleukin-1 receptor antagonist gene Biochem Biophys Res Commun 1999, 263:702-706. 10.1006/bbrc.1999.1440 10512743
8. Pan G Risser P Mao W Baldwin DT Zhong AW Filvaroff E Yansura D Lewis L Eigenbrot C Henzel WJ Vandlen R IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp Cytokine 2001, 13:1-7. 10.1006/ cyto.2000.0799 11145836
9. Towne JE Garka KE Renshaw BR Virca GD Sims JE Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs J Biol Chem 2004, 279:13677-13688. 10.1074/jbc.M400117200 14734551
10. Magne D Palmer G Barton JL Mézin F Talabot-Ayer D Bas S Duffy T Noger M Guerne PA Nicklin MJ Gabay C The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes Arthritis Res Ther 2006, 8:R80. 1526623 16646978 10.1186/ar1946
11. Blumberg H Dinh H Trueblood ES Pretorius J Kugler D Weng N Kanaly ST Towne JE Willis CR Kuechle MK Sims JE Peschon JJ Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation J Exp Med 2007, 204:2603-2614. 2118475 17908936 10.1084/jem.20070157
12. Schmitz J Owyang A Oldham E Song Y Murphy E McClanahan TK Zurawski G Moshrefi M Qin J Li X Gorman DM Bazan JF Kastelein RA IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 2005, 23:479-490. 10.1016/j.immuni.2005.09.015 16286016
13. Brint EK Fitzgerald KA Smith P Coyle AJ Gutierrez-Ramos JC Fallon PG O'Neill LA Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction J Biol Chem 2002, 277:49205-49211. 10.1074/jbc.M209685200 12368275
14. Baekkevold ES Roussigne M Yamanaka T Johansen FE Jahnsen FL Amalric F Brandtzaeg P Erard M Haraldsen G Girard JP Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules Am J Pathol 2003, 163:69-79. 1868188 12819012
15. Werman A Werman-Venkert R White R Lee JK Werman B Krelin Y Voronov E Dinarello CA Apte RN The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription Proc Natl Acad Sci USA 2004, 101:2434-2439. 356968 14983027 10.1073/pnas.0308705101
16. Carriere V Roussel L Ortega N Lacorre DA Americh L Aguilar L Bouche G Girard JP IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo Proc Natl Acad Sci USA 2007, 104:282-287. 1765450 17185418 10.1073/pnas.0606854104
17. Hayakawa H Hayakawa M Kume A Tominaga S Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation J Biol Chem 2007, 282:26369-26380. 10.1074/jbc.M704916200 17623648
18. Trajkovic V Sweet MJ Xu D T1/ST2 - an IL-1 receptor-like modulator of immune responses Cytokine Growth Factor Rev 2004, 15:87-95. 10.1016/ j.cytogfr.2004.02.004 15110792
19. Brunner M Krenn C Roth G Moser B Dworschak M Jensen-Jarolim E Spittler A Sautner T Bonaros N Wolner E Boltz-Nitulescu G Ankersmit HJ Increased levels of soluble ST2 protein and IgG1 production in patients with sepsis and trauma Intensive Care Med 2004, 30:1468-1473. 10.1007/ s00134-004-2184-x 14991091
20. Brint EK Xu D Liu H Dunne A McKenzie AN O'Neill LA Liew FY ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance Nat Immunol 2004, 5:373-379. 10.1038/ ni1050 15004556
21. Sweet MJ Leung BP Kang D Sogaard M Schulz K Trajkovic V Campbell CC Xu D Liew FY A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression J Immunol 2001, 166:6633-6639. 11359817
22. Yin H Huang BJ Yang H Huang YF Xiong P Zheng F Chen XP Chen YF Gong FL Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury Biochem Biophys Res Commun 2006, 351:940-946. 10.1016/ j.bbrc.2006.10.166 17097607
23. Fagundes CT Amaral FA Souza AL Vieira AT Xu D Liew FY Souza DG Teixeira MM ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion J Leukoc Biol 2007, 81:492-499. 10.1189/jlb.0606422 17099102
24. Miller AM Xu D Asquith DL Denby L Li Y Sattar N Baker AH McInnes IB Liew FY IL-33 reduces the development of atherosclerosis J Exp Med 2008, 205:339-346. 2271006 18268038 10.1084/jem.20071868
25. Lee DM Friend DS Gurish MF Benoist C Mathis D Brenner MB Mast cells: A cellular link between autoantibodies and inflammatory arthritis Science 2002, 297:1689-1692. 10.1126/science.1073176 12215644
26. Nigrovic PA Binstadt BA Monach PA Johnsen A Gurish M Iwakura Y Benoist C Mathis D Lee DM Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1 Proc Natl Acad Sci USA 2007, 104:2325-2330. 1892913 17277081 10.1073/pnas.0610852103
27. Leung BP Xu D Culshaw S McInnes IB Liew FY A novel therapy of murine collagen-induced arthritis with soluble T1/ST2 J Immunol 2004, 173:145-150. 15210768
28. Xu D Jiang HR Kewin P Li Y Mu R Fraser AR Pitman N Kurowska-Stolarska M McKenzie AN McInnes IB Liew FY IL-33 exacerbates antigen-induced arthritis by activating mast cells Proc Natl Acad Sci USA 2008, 105:10913-10918. 2491487 18667700 10.1073/pnas.0801898105
29. Palmer G Talabot-Ayer D Lamacchia C Toy D Seemayer CA Viatte S Finckh A Smith DE Gabay C Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis Arthritis Rheum 2009, 60:738-749. 10.1002/art.24305 19248109
30. Smith DE Renshaw BR Ketchem RR Kubin M Garka KE Sims JE Four new members expand the interleukin-1 superfamily J Biol Chem 2000, 275:1169-1175. 10.1074/jbc.275.2.1169 10625660
31. Bufler P Azam T Gamboni-Robertson F Reznikov LL Kumar S Dinarello CA Kim SH A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity Proc Natl Acad Sci USA 2002, 99:13723-13728. 129755 12381835 10.1073/pnas.212519099
32. Lin H Ho AS Haley-Vicente D Zhang J Bernal-Fussell J Pace AM Hansen D Schweighofer K Mize NK Ford JE Cloning and characterization of IL-1HY2, a novel interleukin-1 family member J Biol Chem 2001, 276:20597-20602. 10.1074/jbc.M010095200 11278614
33. Arend WP Palmer G Gabay C IL-1, IL-18, and IL-33 families of cytokines Immunol Rev 2008, 223:20-38. 10.1111/j.1600-065X.2008.00624.x 18613828
34. Gracie JA Forsey RJ Chan WL Gilmour A Leung BP Greer MR Kennedy K Carter R Wei XQ Xu D Field M Foulis A Liew FY McInnes IB A proinflammatory role for IL-18 in rheumatoid arthritis J Clin Invest 1999, 104:1393-1401. 409841 10562301 10.1172/JCI7317
35. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells J Immunol 1997, 159:97-106. 9200444
36. Pizarro TT Michie MH Bentz M Woraratanadharm J Smith MF Jr Foley E Moskaluk CA Bickston SJ Cominelli F IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells J Immunol 1999, 162:6829-6835. 10352304
37. Prinz M Hanisch UK Murine microglial cells produce and respond to interleukin-18 J Neurochem 1999, 72:2215-2218. 10.1046/ j.1471-4159.1999.0722215.x 10217305
38. Stoll S Jonuleit H Schmitt E Muller G Yamauchi H Kurimoto M Knop J Enk AH Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development Eur J Immunol 1998, 28:3231-3239. 10.1002/ (SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q 9808192
39. Gu Y Kuida K Tsutsui H Ku G Hsiao K Fleming MA Hayashi N Higashino K Okamura H Nakanishi K Kurimoto M Tanimoto T Flavell RA Sato V Harding MW Livingston DJ Su MS Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme Science 1997, 275:206-209. 10.1126/science.275.5297.206 8999548
40. Ghayur T Banerjee S Hugunin M Butler D Herzog L Carter A Quintal L Sekut L Talanian R Paskind M Wong W Kamen R Tracey D Allen H Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production Nature 1997, 386:619-623. 10.1038/386619a0 9121587
41. Ferrari D Pizzirani C Adinolfi E Lemoli RM Curti A Idzko M Panther E Di Virgilio F The P2X7 receptor: A key player in IL-1 processing and release J Immunol 2006, 176:3877-3883. 16547218
42. Cheung H Chen NJ Cao Z Ono N Ohashi PS Yeh WC Accessory protein-like is essential for IL-18-mediated signaling J Immunol 2005, 174:5351-5357. 15843532
43. van Kuijk AW Reinders-Blankert P Smeets TJ Dijkmans BA Tak PP Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: Implications for treatment Ann Rheum Dis 2006, 65:1551-1557. 10.1136/ard.2005.050963 16728461
44. Rooney T Murphy E Benito M Roux-Lombard P FitzGerald O Dayer JM Bresnihan B Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis Ann Rheum Dis 2004, 63:1393-1398. 1754818 15479888 10.1136/ard.2003.016428
45. Yamada N Niwa S Tsujimura T Iwasaki T Sugihara A Futani H Hayashi S Okamura H Akedo H Terada N Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity Bone 2002, 30:901-908. 10.1016/S8756-3282(02)00722-6 12052461
46. Tak PP Bacchi M Bertolino M Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis Eur J Drug Metab Pharmacokinet 2006, 31:109-116. 16898079
47. Kim SH Han SY Azam T Yoon DY Dinarello CA Interleukin-32: A cytokine and inducer of TNFalpha Immunity 2005, 22:131-142. 15664165
48. Dinarello CA Kim SH IL-32, a novel cytokine with a possible role in disease Ann Rheum Dis 2006, 65(Suppl 3):iIi61-64. 10.1136/ ard.2006.058511 17038476
49. Netea MG Azam T Lewis EC Joosten LA Wang M Langenberg D Meng X Chan ED Yoon DY Ottenhoff T Kim SH Dinarello CA Mycobacterium tuberculosis induces interleukin-32 production through a caspase-1/IL-18/ interferon-gamma-dependent mechanism PLoS Med 2006, 3:e277. 1539091 16903774 10.1371/journal.pmed.0030277
50. McInnes IB al-Mughales J Field M Leung BP Huang FP Dixon R Sturrock RD Wilkinson PC Liew FY The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis Nat Med 1996, 2:175-182. 10.1038/ nm0296-175 8574962
51. Harada S Yamamura M Okamoto H Morita Y Kawashima M Aita T Makino H Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis Arthritis Rheum 1999, 42:1508-1516. 10.1002/ 1529-0131(199907)42:7<1508::AID-ANR26>3.0.CO;2-L 10403280
52. Grabstein KH Eisenman J Shanebeck K Rauch C Srinivasan S Fung V Beers C Richardson J Schoenborn MA Ahdieh M Johnson L Alderson MR Watson JD Anderson DM Giri JG Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor Science 1994, 264:965-968. 10.1126/science.8178155 8178155
53. Waldmann TA Tagaya Y The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens Annu Rev Immunol 1999, 17:19-49. 10.1146/annurev.immunol.17.1.19 10358752
54. Onu A Pohl T Krause H Bulfone-Paus S Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms J Immunol 1997, 158:255-262. 8977197
55. Tagaya Y Kurys G Thies TA Losi JM Azimi N Hanover JA Bamford RN Waldmann TA Generation of secretable and non-secretable interleukin 15 isoforms through alternate usage of signal peptides Proc Natl Acad Sci USA 1997, 94:14444-14449. 25016 9405632 10.1073/pnas.94.26.14444
56. Bulanova E Budagian V Orinska Z Krause H Paus R Bulfone-Paus S Mast cells express novel functional IL-15 receptor alpha isoforms J Immunol 2003, 170:5045-5055. 12734349
57. Dubois S Mariner J Waldmann TA Tagaya Y IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells Immunity 2002, 17:537-547. 10.1016/S1074-7613(02)00429-6 12433361
58. Tagaya Y Bamford RN DeFilippis AP Waldmann TA IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels Immunity 1996, 4:329-336. 10.1016/ S1074-7613(00)80246-0 8612127
59. Tagaya Y Burton JD Miyamoto Y Waldmann TA Identification of a novel receptor/signal transduction pathway for IL-15/T in mast cells EMBO J 1996, 15:4928-4939. 452230 8890166
60. McInnes IB Gracie JA Interleukin-15: A new cytokine target for the treatment of inflammatory diseases Curr Opin Pharmacol 2004, 4:392-397. 10.1016/j.coph.2004.04.003 15251134
61. Lodolce J Burkett P Koka R Boone D Chien M Chan F Madonia M Chai S Ma A Interleukin-15 and the regulation of lymphoid homeostasis Mol Immunol 2002, 39:537-544. 10.1016/S0161-5890(02)00211-0 12431387
62. Kane D Gogarty M O'Leary J Silva I Bermingham N Bresnihan B Fitzgerald O Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate Arthritis Rheum 2004, 50:3286-3295. 10.1002/art.20518 15476228
63. Smolewska E Brozik H Smolewski P Biernacka-Zielinska M Darzynkiewicz Z Stanczyk J Apoptosis of peripheral blood lymphocytes in patients with juvenile idiopathic arthritis Ann Rheum Dis 2003, 62:761-763. 1754617 12860732 10.1136/ard.62.8.761
64. Chan A Filer A Parsonage G Kollnberger S Gundle R Buckley CD Bowness P Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells Arthritis Rheum 2008, 58:707-717. 10.1002/art.23264 18311795
65. Kurowska M Rudnicka W Kontny E Janicka I Chorazy M Kowalczewski J Ziolkowska M Ferrari-Lacraz S Strom TB Maslinski W Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: Endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2 J Immunol 2002, 169:1760-1767. 12165497
66. Wakisaka S Suzuki N Nagafuchi H Takeba Y Kaneko A Asai T Sakane T Characterization of tissue outgrowth developed in vitro in patients with rheumatoid arthritis: Involvement of T cells in the development of tissue outgrowth Int Arch Allergy Immunol 2000, 121:68-79. 10.1159/ 000024299 10686511
67. Ling SM Patel DD Garnero P Zhan M Vaduganathan M Muller D Taub D Bathon JM Hochberg M Abernethy DR Metter EJ Ferrucci L Serum protein signatures detect early radiographic osteoarthritis Osteoarthritis Cartilage 2009, 17:43-48. 10.1016/j.joca.2008.05.004 18571442
68. Ziolkowska M Koc A Luszczykiewicz G Ksiezopolska-Pietrzak K Klimczak E Chwalinska-Sadowska H Maslinski W High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism J Immunol 2000, 164:2832-2838. 10679127
69. Sen M Lauterbach K El-Gabalawy H Firestein GS Corr M Carson DA Expression and function of wingless and frizzled homologs in rheumatoid arthritis Proc Natl Acad Sci USA 2000, 97:2791-2796. 16008 10688908 10.1073/pnas.050574297
70. Spolski R Leonard WJ The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer Curr Opin Immunol 2008, 20:295-301. 10.1016/ j.coi.2008.02.004 18554883
71. Ettinger R Kuchen S Lipsky PE The role of IL-21 in regulating B-cell function in health and disease Immunol Rev 2008, 223:60-86. 10.1111/ j.1600-065X.2008.00631.x 18613830
72. Vogelzang A McGuire HM Yu D Sprent J Mackay CR King C A fundamental role for interleukin-21 in the generation of T follicular helper cells Immunity 2008, 29:127-137. 10.1016/j.immuni.2008.06.001 18602282
73. Yang L Anderson DE Baecher-Allan C Hastings WD Bettelli E Oukka M Kuchroo VK Hafler DA IL-21 and TGF-beta are required for differentiation of human T(H)17 cells Nature 2008, 454:350-352. 10.1038/nature07021 18469800
74. Huber M Brustle A Reinhard K Guralnik A Walter G Mahiny A von Low E Lohoff M IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype Proc Natl Acad Sci USA 2008, 105:20846-20851. 10.1073/pnas.0809077106 19088203
75. Bauquet AT Jin H Paterson AM Mitsdoerffer M Ho IC Sharpe AH Kuchroo VK The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells Nat Immunol 2009, 10:167-175. 10.1038/ni.1690 19098919
76. Thedrez A Harly C Morice A Salot S Bonneville M Scotet E IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human Vgamma9Vdelta2 T cells for adoptive immunotherapy J Immunol 2009, 182:3423-3431. 10.4049/jimmunol.0803068 19265120
77. Liu Z Yang L Cui Y Wang X Guo C Huang Z Kan Q Liu Y Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease Inflamm Bowel Dis 2009.
78. Pesu M Laurence A Kishore N Zwillich SH Chan G O'Shea JJ Therapeutic targeting of Janus kinases Immunol Rev 2008, 223:132-142. 2634846 18613833 10.1111/j.1600-065X.2008.00644.x
79. Williams W Scherle P Shi J Newton R McKeever E Fridman J Burn T Vaddi K Levy R Moreland L A randomized placebo-controlled study of INCB01 a selective janus kinase 1 & 2 (JAK1 & 2) inhibitor in rheumatoid arthritis (RA) [abstract] Arthritis Rheum 2008, 58:S431-S431.
80. Langrish CL McKenzie BS Wilson NJ de Waal Malefyt R Kastelein RA Cua DJ IL-12 and IL-23: Master regulators of innate and adaptive immunity Immunol Rev 2004, 202:96-105. 10.1111/j.0105-2896.2004.00214.x 15546388
81. Kastelein RA Hunter CA Cua DJ Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation Annu Rev Immunol 2007, 25:221-242. 10.1146/annurev.immunol.22.012703.104758 17291186
82. Villarino AV Stumhofer JS Saris CJ Kastelein RA de Sauvage FJ Hunter CA IL-27 limits IL-2 production during Th1 differentiation J Immunol 2006, 176:237-247. 16365415
83. Villarino A Hibbert L Lieberman L Wilson E Mak T Yoshida H Kastelein RA Saris C Hunter CA The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection Immunity 2003, 19:645-655. 10.1016/ S1074-7613(03)00300-5 14614852
84. Fitzgerald DC Ciric B Touil T Harle H Grammatikopolou J Das Sarma J Gran B Zhang GX Rostami A Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis J Immunol 2007, 179:3268-3275. 17709543
85. Batten M Li J Yi S Kljavin NM Danilenko DM Lucas S Lee J de Sauvage FJ Ghilardi N Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nat Immunol 2006, 7:929-936. 10.1038/ni1375 16906167
86. Niedbala W Cai B Wei X Patakas A Leung BP McInnes IB Liew FY Interleukin 27 attenuates collagen-induced arthritis Ann Rheum Dis 2008, 67:1474-1479. 10.1136/ard.2007.083360 18199596
87. Collison LW Workman CJ Kuo TT Boyd K Wang Y Vignali KM Cross R Sehy D Blumberg RS Vignali DA The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 2007, 450:566-569. 10.1038/nature06306 18033300
88. Niedbala W Wei XQ Cai B Hueber AJ Leung BP McInnes IB Liew FY IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells Eur J Immunol 2007, 37:3021-3029. 10.1002/eji.200737810 17874423
89. Yao Z Painter SL Fanslow WC Ulrich D Macduff BM Spriggs MK Armitage RJ Human IL-17: A novel cytokine derived from T cells J Immunol 1995, 155:5483-5486. 7499828
90. Moseley TA Haudenschild DR Rose L Reddi AH Interleukin-17 family and IL-17 receptors Cytokine Growth Factor Rev 2003, 14:155-174. 10.1016/ S1359-6101(03)00002-9 12651226
91. + T cells J Biol Chem 2007, 282:13447-13455. 10.1074/ jbc.M700499200 17355969
92. Kuestner RE Taft DW Haran A Brandt CS Brender T Lum K Harder B Okada S Ostrander CD Kreindler JL Aujla SJ Reardon B Moore M Shea P Schreckhise R Bukowski TR Presnell S Guerra-Lewis P Parrish-Novak J Ellsworth JL Jaspers S Lewis KE Appleby M Kolls JK Rixon M West JW Gao Z Levin SD Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F J Immunol 2007, 179:5462-5473. 17911633
93. Wright JF Bennett F Li B Brooks J Luxenberg DP Whitters MJ Tomkinson KN Fitz LJ Wolfman NM Collins M Dunussi-Joannopoulos K Chatterjee-Kishore M Carreno BM The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex J Immunol 2008, 181:2799-2805. 18684971
94. Haudenschild D Moseley T Rose L Reddi AH Soluble and transmembrane isoforms of novel interleukin-17 receptor-like protein by RNA splicing and expression in prostate cancer J Biol Chem 2002, 277:4309-4316. 10.1074/jbc.M109372200 11706037
95. Novatchkova M Leibbrandt A Werzowa J Neubuser A Eisenhaber F The STIR-domain superfamily in signal transduction, development and immunity Trends Biochem Sci 2003, 28:226-229. 10.1016/S0968-0004(03)00067-7 12765832
96. Qian Y Liu C Hartupee J Altuntas CZ Gulen MF Jane-Wit D Xiao J Lu Y Giltiay N Liu J Kordula T Zhang QW Vallance B Swaidani S Aronica M Tuohy VK Hamilton T Li X The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease Nat Immunol 2007, 8:247-256. 10.1038/ni1439 17277779
97. Li X Act1 modulates autoimmunity through its dual functions in CD40L/ BAFF and IL-17 signaling Cytokine 2008, 41:105-113. 10.1016/ j.cyto.2007.09.015 18061473
98. Romagnani S Human Th17 cells Arthritis Res Ther 2008, 10:206. 2453756 18466633 10.1186/ar2392
99. Gately MK Renzetti LM Magram J Stern AS Adorini L Gubler U Presky DH The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses Annu Rev Immunol 1998, 16:495-521. 10.1146/ annurev.immunol.16.1.495 9597139
100. Bettelli E Sullivan B Szabo SJ Sobel RA Glimcher LH Kuchroo VK Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis J Exp Med 2004, 200:79-87. 2213316 15238607 10.1084/jem.20031819
101. Hunter CA New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions Nat Rev Immunol 2005, 5:521-531. 10.1038/nri1648 15999093
102. McKenzie BS Kastelein RA Cua DJ Understanding the IL-23-IL-17 immune pathway Trends Immunol 2006, 27:17-23. 10.1016/j.it.2005.10.003 16290228
103. Cua DJ Sherlock J Chen Y Murphy CA Joyce B Seymour B Lucian L To W Kwan S Churakova T Zurawski S Wiekowski M Lira SA Gorman D Kastelein RA Sedgwick JD Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain Nature 2003, 421:744-748. 10.1038/nature01355 12610626
104. Murphy CA Langrish CL Chen Y Blumenschein W McClanahan T Kastelein RA Sedgwick JD Cua DJ Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation J Exp Med 2003, 198:1951-1957. 2194162 14662908 10.1084/jem.20030896
105. Duerr RH Taylor KD Brant SR Rioux JD Silverberg MS Daly MJ Steinhart AH Abraham C Regueiro M Griffiths A Dassopoulos T Bitton A Yang H Targan S Datta LW Kistner EO Schumm LP Lee AT Gregersen PK Barmada MM Rotter JI Nicolae DL Cho JH A genome-wide association study identifies IL23R as an inflammatory bowel disease gene Science 2006, 314:1461-1463. 10.1126/ science.1135245 17068223
106. Cargill M Schrodi SJ Chang M Garcia VE Brandon R Callis KP Matsunami N Ardlie KG Civello D Catanese JJ Leong DU Panko JM McAllister LB Hansen CB Papenfuss J Prescott SM White TJ Leppert MF Krueger GG Begovich AB A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Am J Hum Genet 2007, 80:273-290. 1785338 17236132 10.1086/511051
107. Mannon PJ Fuss IJ Mayer L Elson CO Sandborn WJ Present D Dolin B Goodman N Groden C Hornung RL Quezado M Yang Z Neurath MF Salfeld J Veldman GM Schwertschlag U Strober W Anti-IL-12 Crohn's Disease Study Group Anti-interleukin-12 antibody for active Crohn's disease N Engl J Med 2004, 351:2069-2079. 10.1056/NEJMoa033402 15537905
108. Krueger GG Langley RG Leonardi C Yeilding N Guzzo C Wang Y Dooley LT Lebwohl M A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis N Engl J Med 2007, 356:580-592. 10.1056/ NEJMoa062382 17287478
109. Gottlieb A Menter A Mendelsohn A Shen YK Li S Guzzo C Fretzin S Kunynetz R Kavanaugh A Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: Randomised, double-blind, placebo-controlled, crossover trial Lancet 2009, 373:633-640. 10.1016/ S0140-6736(09)60140-9 19217154
110. Bettelli E Carrier Y Gao W Korn T Strom TB Oukka M Weiner HL Kuchroo VK Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 2006, 441:235-238. 10.1038/ nature04753 16648838
111. Mangan PR Harrington LE O'Quinn DB Helms WS Bullard DC Elson CO Hatton RD Wahl SM Schoeb TR Weaver CT Transforming growth factor-beta induces development of the T(H)17 lineage Nature 2006, 441:231-234. 10.1038/ nature04754 16648837
112. Veldhoen M Hocking RJ Atkins CJ Locksley RM Stockinger B TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 2006 24 179 189 10.1016/j.immuni.2006.01.001 16473830
113. Korn T Bettelli E Gao W Awasthi A Jager A Strom TB Oukka M Kuchroo VK IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells Nature 2007, 448:484-487. 10.1038/nature05970 17581588
114. Acosta-Rodriguez EV Napolitani G Lanzavecchia A Sallusto F Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 2007, 8:942-949. 10.1038/ni1496 17676045
115. Wilson NJ Boniface K Chan JR McKenzie BS Blumenschein WM Mattson JD Basham B Smith K Chen T Morel F Lecron JC Kastelein RA Cua DJ McClanahan TK Bowman EP de Waal Malefyt R Development, cytokine profile and function of human interleukin 17-producing helper T cells Nat Immunol 2007, 8:950-957. 10.1038/ni1497 17676044
116. Manel N Unutmaz D Littman DR The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Nat Immunol 2008, 9:641-649. 2597394 18454151 10.1038/ ni.1610
117. + T helper cells Cell 2006, 126:1121-1133. 10.1016/j.cell.2006.07.035 16990136
118. Yang XO Panopoulos AD Nurieva R Chang SH Wang D Watowich SS Dong C STAT3 regulates cytokine-mediated generation of inflammatory helper T cells J Biol Chem 2007, 282:9358-9363. 10.1074/jbc.C600321200 17277312
119. Zhou L Lopes JE Chong MM Ivanov II Min R Victora GD Shen Y Du J Rubtsov YP Rudensky AY Ziegler SF Littman DR TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function Nature 2008, 453:236-240. 2597437 18368049 10.1038/nature06878
120. Gavin MA Rasmussen JP Fontenot JD Vasta V Manganiello VC Beavo JA Rudensky AY Foxp3-dependent programme of regulatory T-cell differentiation Nature 2007, 445:771-775. 10.1038/nature05543 17220874
121. Williams LM Rudensky AY Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 Nat Immunol 2007, 8:277-284. 10.1038/ni1437 17220892
122. Bettelli E Korn T Oukka M Kuchroo VK Induction and effector functions of T(H)17 cells Nature 2008, 453:1051-1057. 10.1038/nature07036 18563156
123. Kolls JK Linden A Interleukin-17 family members and inflammation Immunity 2004, 21:467-476. 10.1016/j.immuni.2004.08.018 15485625
124. Nakae S Saijo S Horai R Sudo K Mori S Iwakura Y IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist Proc Natl Acad Sci USA 2003, 100:5986-5990. 156313 12721360 10.1073/ pnas.1035999100
125. Fossiez F Djossou O Chomarat P Flores-Romo L Ait-Yahia S Maat C Pin JJ Garrone P Garcia E Saeland S Blanchard D Gaillard C Das Mahapatra B Rouvier E Golstein P Banchereau J Lebecque S T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines J Exp Med 1996, 183:2593-2603. 2192621 8676080 10.1084/ jem.183.6.2593
126. Gaffen SL An overview of IL-17 function and signaling Cytokine 2008, 43:402-407. 10.1016/j.cyto.2008.07.017 18701318
127. Park H Li Z Yang XO Chang SH Nurieva R Wang YH Wang Y Hood L Zhu Z Tian Q Dong C A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 Nat Immunol 2005, 6:1133-1141. 1618871 16200068 10.1038/ni1261
128. Miossec P Interleukin-17 in rheumatoid arthritis: If T cells were to contribute to inflammation and destruction through synergy Arthritis Rheum 2003, 48:594-601. 10.1002/art.10816 12632409
129. Chabaud M Page G Miossec P Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: Regulation by soluble receptors and Th2 cytokines J Immunol 2001, 167:6015-6020. 11698482
130. Lubberts E Joosten LA Loo van de FA Gersselaar van den LA Berg van den WB Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4 Arthritis Rheum 2000, 43:1300-1306. 10.1002/
131. Lubberts E Bersselaar van den L Oppers-Walgreen B Schwarzenberger P Coenen-de Roo CJ Kolls JK Joosten LA Berg van den WB IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance J Immunol 2003, 170:2655-2662. 12594294
132. Nakae S Nambu A Sudo K Iwakura Y Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice J Immunol 2003, 171:6173-6177. 14634133
133. Lubberts E Schwarzenberger P Huang W Schurr JR Peschon JJ Berg van den WB Kolls JK Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis J Immunol 2005, 175:3360-3368. 16116229
134. Cho ML Kang JW Moon YM Nam HJ Jhun JY Heo SB Jin HT Min SY Ju JH Park KS Cho YG Yoon CH Park SH Sung YC Kim HY STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice J Immunol 2006, 176:5652-5661. 16622035
135. Abdollahi-Roodsaz S Joosten LA Koenders MI Devesa I Roelofs MF Radstake TR Heuvelmans-Jacobs M Akira S Nicklin MJ Ribeiro-Dias F Berg van den WB Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis J Clin Invest 2008, 118:205-216. 2104479 18060042 10.1172/JCI32639